Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.78B |
| 2 |
Amazon
AMZN
|
+$1.07B |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$974M |
| 4 |
Meta Platforms (Facebook)
META
|
+$959M |
| 5 |
Linde
LIN
|
+$857M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$1.91B |
| 2 |
Broadcom
AVGO
|
+$1.31B |
| 3 |
Caterpillar
CAT
|
+$1.21B |
| 4 |
Travelers Companies
TRV
|
+$760M |
| 5 |
ConocoPhillips
COP
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.61% |
| 2 | Financials | 14.89% |
| 3 | Communication Services | 14.22% |
| 4 | Healthcare | 12.5% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
International Flavors & Fragrances
IFF
$21.4B
| $888M | 0.19% |
5,893,765
+9,019
| +0.2% | +$1.31M |
|
127
Edison International
EIX
$26.7B
| $854M | 0.18% |
12,519,754
+9,800,598
| +360% | +$621M |
|
128
NovoCure
NVCR
$2.05B
| $851M | 0.18% |
11,332,005
+775,189
| +7% | +$77.8M |
|
129
GSK
GSK
$101B
| $843M | 0.18% |
15,294,581
-2,833,588
| -16% | -$147M |
|
130
Altria Group
MO
$107B
| $840M | 0.18% |
17,727,541
+1,348,687
| +8% | +$61.8M |
|
|
AVGOP
131
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $838M | 0.18% |
+403,937
| New | +$707M |
|
132
NVR
NVR
$16.8B
| $822M | 0.17% |
139,098
-35,487
| -20% | -$187M |
|
133
MKS Inc
MKSI
$20.7B
| $821M | 0.17% |
4,711,201
+186,780
| +4% | +$29.2M |
|
134
General Motors
GM
$76.1B
| $802M | 0.17% |
13,682,486
+13,676,219
| +218,226% | +$799M |
|
135
Costco
COST
$421B
| $770M | 0.16% |
1,357,368
+7,557
| +0.6% | +$3.87M |
|
|
ABB
136
DELISTED
ABB Ltd
ABB
| $770M | 0.16% |
20,173,133
+324,811
| +2% | +$11.4M |
|
137
TFI International
TFII
$12B
| $759M | 0.16% |
6,777,111
+1,751,258
| +35% | +$191M |
|
|
NBIS
138
Nebius Group N.V.
NBIS
$65.8B
| $750M | 0.16% |
12,401,049
-487,872
| -4% | -$35.9M |
|
139
CMS Energy
CMS
$22B
| $749M | 0.16% |
11,518,370
+17,469
| +0.2% | +$1.07M |
|
140
MSCI
MSCI
$40.9B
| $742M | 0.16% |
1,210,776
-219,187
| -15% | -$137M |
|
141
Concentrix
CNXC
$1.5B
| $736M | 0.16% |
4,120,003
+618,620
| +18% | +$110M |
|
142
Strategy Inc
MSTR
$37.3B
| $729M | 0.15% |
13,386,250
+2,881,040
| +27% | +$198M |
|
143
Zimmer Biomet
ZBH
$18.7B
| $703M | 0.15% |
5,696,429
+1,667,139
| +41% | +$218M |
|
|
144
Enbridge
ENB
$112B
| $697M | 0.15% |
17,838,401
-47,557,253
| -73% | -$1.91B |
|
|
BHVN
145
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $690M | 0.15% |
5,005,826
-359,239
| -7% | -$45.7M |
|
|
EA
146
DELISTED
Electronic Arts
EA
| $688M | 0.15% |
5,213,684
-1,230,418
| -19% | -$165M |
|
|
ATH
147
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $686M | 0.15% |
8,235,931
+2,291,859
| +39% | +$188M |
|
148
Hormel Foods
HRL
$13.4B
| $673M | 0.14% |
13,780,558
+2,463,310
| +22% | +$108M |
|
149
Kraft Heinz
KHC
$29.1B
| $661M | 0.14% |
18,412,362
+39,508
| +0.2% | +$1.42M |
|
150
Celanese
CE
$4.75B
| $641M | 0.14% |
3,813,164
-1,976,292
| -34% | -$322M |
|
Similar funds
Capital International Investors's Q4 2021 Portfolio in Review
As of Q4 2021, Capital International Investors held 484 positions worth $473B, up 8.1% from $437B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital International Investors's Q4 2021 filing shows 27 new, 228 increased, 149 reduced and 24 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 403,937 shares worth $838M. The largest sale was Enbridge, an estimated $1.91B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.
- Capital International Investors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 403,937 shares worth $838M.
- Capital International Investors added most to Coupang in Q4 2021, an estimated $1.78B increase.
- Capital International Investors's biggest Q4 2021 reduction was Enbridge, cutting an estimated $1.91B.
- Capital International Investors fully exited CDK Global, Inc. in Q4 2021, selling an estimated $179M.
- Capital International Investors's ten largest holdings make up 30% of its $473B portfolio in Q4 2021.
- Capital International Investors opened 27 new positions and closed 24 in Q4 2021.
- Capital International Investors's portfolio value rose 8.1% quarter-over-quarter to $473B.
Based on Capital International Investors's 13F filing for Q4 2021, filed 14 Feb 2022.